Menu
GeneBe

rs78001248

Variant summary

Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_001615.4(ACTG2):​c.532C>T​(p.Arg178Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R178H) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

ACTG2
NM_001615.4 missense

Scores

13
1
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9O:1

Conservation

PhyloP100: 7.91
Variant links:
Genes affected
ACTG2 (HGNC:145): (actin gamma 2, smooth muscle) Actins are highly conserved proteins that are involved in various types of cell motility and in the maintenance of the cytoskeleton. Three types of actins, alpha, beta and gamma, have been identified in vertebrates. Alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. This gene encodes actin gamma 2; a smooth muscle actin found in enteric tissues. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Based on similarity to peptide cleavage of related actins, the mature protein of this gene is formed by removal of two N-terminal peptides.[provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 17 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-73913566-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 132801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant where missense usually causes diseases, ACTG2
PP3
MetaRNN computational evidence supports a deleterious effect, 0.966
PP5
Variant 2-73913565-C-T is Pathogenic according to our data. Variant chr2-73913565-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 132800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-73913565-C-T is described in Lovd as [Pathogenic]. Variant chr2-73913565-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACTG2NM_001615.4 linkuse as main transcriptc.532C>T p.Arg178Cys missense_variant 6/9 ENST00000345517.8
ACTG2NM_001199893.2 linkuse as main transcriptc.403C>T p.Arg135Cys missense_variant 5/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACTG2ENST00000345517.8 linkuse as main transcriptc.532C>T p.Arg178Cys missense_variant 6/91 NM_001615.4 P1P63267-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Visceral myopathy 1 Pathogenic:3Other:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
not provided, no classification providedliterature onlyGeneReviews-High rate of a poor outcome (mortality and/or multivisceral transplantation) or microcolon -
Pathogenic, criteria provided, single submitterresearchLupski Lab, Baylor-Hopkins CMG, Baylor College of MedicineMar 27, 2014- -
Pathogenic, no assertion criteria providedresearchUOSD Genetics and Genomics of Rare Diseases, Istituto Giannina GasliniMay 02, 2015- -
not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Genetics and Applied Genomics, University Hospital TübingenOct 23, 2020- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxMar 10, 2022Published functional studies demonstrate a lack of mutant protein co-localization with actin filaments and decreased collagen contraction capacity (Halim et al., 2016; Thorson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26813947, 26647307, 24337657, 24676022, 27481187, 32621347, 34980693) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2020- -
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMJun 01, 2014- -
Pathogenic, criteria provided, single submitterclinical testingSeattle Children's Hospital Molecular Genetics Laboratory, Seattle Children's Hospital-The p.Arg178Cys variant (c.532C>T, exon 6) is a recurrent variant that has previously been reported in multiple individuals with MMIHS (PMID: 26647307, PMID: 24337657, PMID: 24676022, PMID: 27481187). The p.Arg178Cys variant is absent from large population cohorts (gnomAD v2.1.1). Further supporting pathogenicity, other missense changes at this same residue (p.Arg178His, p.Arg178Leu, p.Arg178Ser) have also been reported as de novo changes in patients with sporadic MMIHS (PMID: 26647307, PMID: 24337657, PMID: 27481187, PMID: 25998219, PMID: 29608093). -
ACTG2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 17, 2024The ACTG2 c.532C>T variant is predicted to result in the amino acid substitution p.Arg178Cys. This variant was reported in individuals with megacystis-microcolon-intestinal hypoperistalsis syndrome, including multiple de novo cases (Thorson et al. 2014. PubMed ID: 24337657; Wangler et al. 2014. PubMed ID: 24676022; Halim et al. 2015. PubMed ID: 26647307; Moreno et al. 2016. PubMed ID: 27481187). Functional studies showed that this variant impaired polymerization and reduced cell contractility (Halim et al. 2016. PubMed ID: 26647307). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
33
DANN
Uncertain
1.0
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.78
T;.;T
M_CAP
Pathogenic
0.74
D
MetaRNN
Pathogenic
0.97
D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-6.3
D;D;D
REVEL
Pathogenic
0.98
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.12
.;B;B
Vest4
0.86
MutPred
0.81
.;Gain of catalytic residue at L179 (P = 0.0093);Gain of catalytic residue at L179 (P = 0.0093);
MVP
1.0
MPC
1.7
ClinPred
1.0
D
GERP RS
4.9
Varity_R
0.91
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78001248; hg19: chr2-74140692; COSMIC: COSV100609536; COSMIC: COSV100609536; API